Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PLX PHARMA INC.

(PLXP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

PLx Pharma : BWS Financial Initiates Coverage on PLx Pharma With Buy Rating, $29 Price Target

09/21/2021 | 09:46am EDT


© MT Newswires 2021
All news about PLX PHARMA INC.
10/14PLX PHARMA : Addresses 'Confusion' Over US Preventive Services Task Force Recommendations ..
MT
10/14PLx Pharma, Inc. Issues Statement on Recent USPTF Recommendations on Aspirin Therapy fo..
GL
10/14PLX PHARMA : Inc. Issues Statement on Recent USPTF Recommendations on Aspirin Therapy for ..
GL
09/21PLX PHARMA : BWS Financial Initiates Coverage on PLx Pharma With Buy Rating, $29 Price Tar..
MT
09/21PLX PHARMA : Corporate Presentation
PU
09/21PLX PHARMA INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
09/20PLX PHARMA INC.(NASDAQCM : PLXP) added to S&P Global BMI Index
CI
09/09PLX PHARMA : to Present at Upcoming Virtual Healthcare Industry Conferences
AQ
08/26PLX PHARMA : Announces Nationwide Rollout of Aspirin Capsules
MT
08/26PLX PHARMA : VAZALORE™ Now on Shelves; National Media Campaign Launches Today
AQ
More news
Analyst Recommendations on PLX PHARMA INC.
More recommendations
Financials (USD)
Sales 2021 9,34 M - -
Net income 2021 -48,5 M - -
Net Debt 2021 - - -
P/E ratio 2021 -6,17x
Yield 2021 -
Capitalization 364 M 364 M -
Capi. / Sales 2021 38,9x
Capi. / Sales 2022 11,1x
Nbr of Employees 10
Free-Float 90,1%
Chart PLX PHARMA INC.
Duration : Period :
PLx Pharma Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PLX PHARMA INC.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Last Close Price 13,26 $
Average target price 24,00 $
Spread / Average Target 81,0%
EPS Revisions
Managers and Directors
Natasha Giordano President, Chief Executive Officer & Director
Rita M. O'Connor CFO, Head-Manufacturing & Supply Chain
Michael J. Valentino Executive Chairman
Gary S. Balkema Independent Director
Kirk K. Calhoun Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PLX PHARMA INC.146.74%374
JOHNSON & JOHNSON4.12%431 385
ROCHE HOLDING AG15.84%337 562
NOVO NORDISK A/S57.04%239 813
PFIZER, INC.12.25%235 986
ELI LILLY AND COMPANY43.51%219 674